MAPT and Alzheimer disease: We aimed to investigate the cross‐sectional and longitudinal associations between NPSs and plasma markers of p‐tau in DLB and AD, and to explore how AD co‐pathology may contribute to the inherent clinical heterogeneity associated with NPSs.